Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -2 of 2
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/3/2008
 
First Published:
4/13/2007
1.
Phase II Study of a Myeloablative Conditioning Regimen Comprising Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed By Unrelated-Donor Double-Unit Umbilical Cord Blood Transplantation and Parathyroid Hormone in Patients With Hematologic Cancers or Other Diseases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 45
NHLBI
MGH-DFCI-0505380
DFCI-0505380, FHCRC-2136.00, NCT00393380
2.
Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 to 75
Other
04-109
NCT00299780
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute